DMAC — DiaMedica Therapeutics Inc

Ownership history in Informed Momentum Co LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which Informed Momentum Co LLC reported a position in DiaMedica Therapeutics Inc (DMAC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.22% (2023 Q2)
Avg. % of fund
0.15%
First filed
2020 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 91,425 -121,087 -57.0% 0.08% $728K $7.96
2023 Q3 REDUCED 212,512 -57,907 -21.4% 0.11% $548K $2.58
2023 Q2 ADDED 270,419 +162,187 +149.9% 0.22% $1.2M $4.32
2021 Q1 REDUCED 108,232 -1,753 -1.6% 0.15% $990K $9.15
2020 Q4 INITIATED 109,985 — — 0.18% $1.1M $10.14
% of Fund (quarterly)    DMAC price (monthly, adj. close)

Other funds also holding DMAC

As of 2025 Q4 — sorted by position size

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 3Y 7Y 14.39% Bleichroeder LP 3Y 0.54% COOPERMAN LEON G 3Y 7Y 0.53% MAGNOLIA CAPITAL ADVISORS LLC 3Y 0.13% Private Capital Management, LLC 3Y 7Y 0.04% CATALYST FINANCIAL PARTNERS LLC 3Y 0.03% AXQ CAPITAL, LP 3Y 0.02% Truvestments Capital LLC 3Y 7Y 0.01% Meridian Wealth Management, LLC 3Y 7Y 0.01% Stonebridge Capital Advisors LLC 3Y 7Y 0.01%
← Back to Informed Momentum Co LLC Holdings